SWK (NASDAQ:SWKH – Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Thursday, March 5th. Analysts expect SWK to post earnings of $0.52 per share for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 19, 2026 at 10:00 AM ET.
SWK Stock Performance
Shares of NASDAQ SWKH opened at $16.65 on Thursday. SWK has a 12-month low of $13.17 and a 12-month high of $20.49. The company has a market cap of $201.47 million, a PE ratio of 8.95 and a beta of 0.29. The stock has a 50 day simple moving average of $17.23 and a 200-day simple moving average of $16.22. The company has a current ratio of 5.68, a quick ratio of 5.68 and a debt-to-equity ratio of 0.13.
Hedge Funds Weigh In On SWK
A number of institutional investors and hedge funds have recently added to or reduced their stakes in SWKH. Raymond James Financial Inc. increased its position in shares of SWK by 297.5% during the 2nd quarter. Raymond James Financial Inc. now owns 74,657 shares of the company’s stock valued at $1,100,000 after purchasing an additional 55,874 shares during the period. Goldman Sachs Group Inc. boosted its stake in SWK by 142.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 38,400 shares of the company’s stock valued at $660,000 after buying an additional 22,546 shares in the last quarter. NewEdge Advisors LLC boosted its stake in SWK by 5,440.8% during the third quarter. NewEdge Advisors LLC now owns 17,509 shares of the company’s stock valued at $255,000 after buying an additional 17,193 shares in the last quarter. AQR Capital Management LLC grew its holdings in SWK by 31.8% during the fourth quarter. AQR Capital Management LLC now owns 25,603 shares of the company’s stock worth $440,000 after acquiring an additional 6,183 shares during the period. Finally, Bridgeway Capital Management LLC raised its position in SWK by 2.9% in the second quarter. Bridgeway Capital Management LLC now owns 114,277 shares of the company’s stock worth $1,684,000 after acquiring an additional 3,263 shares in the last quarter. 99.27% of the stock is owned by institutional investors.
Analyst Ratings Changes
View Our Latest Research Report on SWK
SWK Company Profile
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance.
Recommended Stories
- Five stocks we like better than SWK
- The Next Commodity Crunch (bigger than oil?)
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Read this or regret it forever
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for SWK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWK and related companies with MarketBeat.com's FREE daily email newsletter.
